首页 > 产品目录 > 免疫学 > 抗体 > Anti-DR5 antibody

Anti-DR5 antibody

产品编号 :
英文名称 :
中文名称 :
产品等级 :
品牌 :
包装规格 交货周期 质量标准 目录价 会员专享价 数量
50ug
- +
产品详情
  • 产品名称

    Anti-DR5抗体
    参阅全部 DR5 一抗

  • 描述

    兔多克隆抗体to DR5

  • 宿主

    Rabbit

  • 经测试应用

    适用于: ICCWBmore details

  • 种属反应性

    与反应: Rat, Human

  • 免疫原

    Synthetic peptide:

    CVPEQEMEVQEPAEPTG

    , corresponding to amino acids 255-270 of Rat DR5.

    Run BLAST with BLAST the sequence with ExPASyRun BLAST with BLAST the sequence with NCBI

  • 阳性对照

    • WB: HeLa, PC12, A549 and HEL 92.1.7 cell lysate. ICC: HeLa and HCT 116 cells

  • 常规说明


    The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.

    If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As

  • 形式

    Liquid

  • 存放说明

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

  • 存储溶液

    Preservative: 0.05% Sodium azide
    Constituents: PBS, 0.1% BSA

  • 纯度

    Immunogen affinity purified

  • 克隆

    多克隆

  • 同种型

    IgG

The Abpromise guarantee

Abpromise™承诺保证使用ab16329于以下的经测试应用

“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。

应用Ab评论说明
ICC

Use a concentration of 2 - 3 µg/ml.

WB(1)

Use a concentration of 1 µg/ml. Predicted molecular weight: 58 kDa.

  • 数据库链接

  • 别名

    • CD262 antibody

    • CD262 antigen antibody

    • Cytotoxic TRAIL receptor 2 antibody

    • Death domain containing receptor for TRAIL/Apo 2L antibody

    • Death receptor 5 antibody

    • DR5 antibody

    • KILLER antibody

    • KILLER/DR5 antibody

    • OTTHUMP00000123492 antibody

    • OTTHUMP00000123493 antibody

    • p53 regulated DNA damage inducible cell death receptor(killer) antibody

    • TNF related apoptosis inducing ligand receptor 2 antibody

    • TNF-related apoptosis-inducing ligand receptor 2 antibody

    • TNFRSF10B antibody

    • TR10B_HUMAN antibody

    • TRAIL R2 antibody

    • TRAIL receptor 2 antibody

    • TRAIL-R2 antibody

    • TRAILR2 antibody

    • TRICK2 antibody

    • TRICK2A antibody

    • TRICK2B antibody

    • TRICKB antibody

    • Tumor necrosis factor receptor like protein ZTNFR9 antibody

    • Tumor necrosis factor receptor superfamily member 10B antibody

    • Tumor necrosis factor receptor superfamily, member 10b antibody

    • ZTNFR9 antibody

    • Fas like protein antibody

    • Apoptosis inducing protein TRICK2A/2B antibody

    • Apoptosis inducing receptor TRAIL R2 antibody

  • Western blot - Anti-DR5 antibody (ab16329)

    Western blot - Anti-DR5 antibody (ab16329)

    All lanes : Anti-DR5 antibody (ab16329) at 1/1000 dilution

    Lane 1 : HeLa cell lysate
    Lane 2 : PC12 cell lysate

    Lysates/proteins at 25 µg per lane.

    Secondary
    All lanes : HRP conjugated anti-rabbit

    Developed using the ECL technique.

    Predicted band size: 58 kDa
    Observed band size: 58 kDa

  • Immunocytochemistry - Anti-DR5 antibody (ab16329)

    Immunocytochemistry - Anti-DR5 antibody (ab16329)

    Immunocytochemistry analysis of DR5 was done on 70% confluent log phase HeLa cell. The cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 10 minutes, and blocked with 1% BSA for 1 hour at room temperature. The cells were labeled with ab16329 at 2 µg/mL in 0.1% BSA and incubated for 3 hours at room temperature and then labeled with Goat anti-Rabbit IgG (H+L) Superclonal™ Secondary Antibody, Alexa Fluor® 488 conjugate at a dilution of 1/2000 for 45 minutes at room temperature (Panel a: green). Nuclei (Panel b: blue) were stained with SlowFade® Gold Antifade Mountant with DAPI. F-actin (Panel c: red) was stained with Alexa Fluor® 555 Rhodamine Phalloidin at 1/300. Panel d is a merged image showing nuclear localization. Panel e is a no primary antibody control. The images were captured at 60X magnification.

  • Western blot - Anti-DR5 antibody (ab16329)

    Western blot - Anti-DR5 antibody (ab16329)

    All lanes : Anti-DR5 antibody (ab16329) at 2 µg/ml

    Lane 1 : A549 cell lysate
    Lane 2 : HEL 92.1.7 cell lysate

    Lysates/proteins at 20 µg per lane.

    Secondary
    All lanes : Goat anti-Rabbit IgG (H+L) Superclonal™ at 1/2500 dilution

    Predicted band size: 58 kDa



    Detected by chemiluminescence

  • Immunocytochemistry - Anti-DR5 antibody (ab16329)

    Immunocytochemistry - Anti-DR5 antibody (ab16329)

    Immunocytochemistry analysis of DR5 (TRAIL-R2) was performed using HCT 116 cells and HCT 116 treated with Thapsigargin (1 µM, 36 hours). The cells were fixed with 4% paraformaldehyde for 10 minutes, and blocked with 2% BSA for 1 hour at room temperature. The cells were labeled with ab16329 at 2 µg/mL in 0.1% BSA and incubated overnight at 4 degree and then labeled with Donkey anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 488 at a dilution of 1/2000 for 45 minutes at room temperature (Panel a: green) in HCT 116 treated cells. Nuclei (Panel b: blue) were stained with ProLong™ Diamond Antifade Mountant with DAPI. F-actin (Panel c: red) was stained with Rhodamine Phalloidin 1/300. Panel d represents the merged image of HCT116 treated cells, which shows higher expression for TRAIL-R2 protein showing localization in nucleus, cytoplasm and membrane. Panel e represents the merged image of untreated HCT 116 cells, that shows lower or no expression for TRAIL-R2 protein. Panel f represents control cells with no primary antibody to assess background. The images were captured at 60X magnification.